Karyon-CTT Ltd

Karyon-CTT is a product-focused biopharmaceutical company dedicated to discovery and development of novel and innovative peptide-based tumor targeting systems.

The Karyon-CTT Targeting Units (TU) are intended for delivery of diagnostic imaging agents or therapeutic compounds to cancer tissue. The Karyon-CTT Targeting Units potentially provide high diagnostic accuracy and therapeutic efficacy while minimising the risk of adverse events. The main focus of the company is in the area of oncology.

Karyon-CTT was founded in 2006 through a merger of two leading cancer targeting companies, CTT Cancer Targeting Technologies Ltd. and Karyon Ltd.